共 50 条
- [23] Hearing Improvement after Bevacizumab for Neurofibromatosis Type 2 NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1810 - 1810
- [27] Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation Child's Nervous System, 2016, 32 : 2403 - 2413
- [29] Pathogenesis and management of type 2 neurofibromatosis EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (03): : 281 - 292
- [30] Management strategies in neurofibromatosis type 2 European Archives of Oto-Rhino-Laryngology, 2003, 260 : 12 - 18